发明授权
- 专利标题: Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom
- 专利标题(中): 治疗哮喘急性加重,降低住院患者的可能性
-
申请号: US13525181申请日: 2012-06-15
-
公开(公告)号: US08420697B2公开(公告)日: 2013-04-16
- 发明人: Kazuko Matsuda , Yuichi Iwaki , Kirk W. Johnson
- 申请人: Kazuko Matsuda , Yuichi Iwaki , Kirk W. Johnson
- 申请人地址: US CA San Diego
- 专利权人: MediciNova, Inc.
- 当前专利权人: MediciNova, Inc.
- 当前专利权人地址: US CA San Diego
- 代理机构: Foley & Lardner LLP
- 代理商 Gilberto M. Villacorta; Photon Rao
- 主分类号: A01N37/00
- IPC分类号: A01N37/00 ; A61K31/21
摘要:
The invention provides a method of improving one or more clinical outcomes of an individual experiencing an acute respiratory attack. The acute respiratory attack may include acute reversible bronchospasm, severe acute bronchospasm, or acute exacerbation of asthma. The method includes administering to an individual suffering from an acute respiratory attack an effective amount of bedoradrine or a pharmaceutically acceptable salt thereof in combination with a standard of care (SOC) treatment regimen.
公开/授权文献
信息查询